M3 Inc. reports 28.6% revenue growth to 264.4 billion yen and 24.4% operating profit increase to 62.3 billion yen in nine-month FY2025, driven by medical platform expansion.
M3's sustained double-digit growth highlights the increasing digitalization of the healthcare industry. Their platform model, which connects pharmaceutical companies with physicians, is proving to be highly effective and scalable, setting a benchmark for other health-tech players in the region.
Revenue increased 28.6% to 264.4 billion yen for the nine months ending Dec 31, 2025.
Operating profit grew 24.4% to 62.3 billion yen.
Net profit attributable to parent rose 28.0% to 41.7 billion yen.
Net profit attributable to parent rose 28.0% to 41.7 billion yen.
Growth was driven by the expansion of its medical platform in Japan and overseas.
Sign in to save notes on signals.
Sign In